Form 4: Cardinal Health Director Azelby Receives RSU Grant

Cardinal Health Director Robert Azelby was granted 1,067 restricted share units, vesting in November 2026, as reported in a recent SEC Form 4 filing.

Summary

• Director Robert Azelby of Cardinal Health Inc. (CAH) acquired 1,067 common shares in the form of restricted share units (RSUs).
• The transaction occurred on November 5, 2025.
• These RSUs were granted at a price of $0 per share, which is typical for such awards.
• Following this transaction, Azelby beneficially owns 4,085 common shares directly.
• The restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• An accompanying Limited Power of Attorney, dated May 5, 2025, authorizes several individuals, including James E. Barnett (who signed the Form 4), to file SEC reports on Azelby's behalf.

Sentiment

Score: 6

Explanation: A routine insider acquisition of restricted stock units by a director, which is a positive for aligning interests but not a significant market-moving event on its own.

Positives

• The grant of restricted share units aligns the director's interests with long-term shareholder value.

Future Outlook

The vesting schedule for the restricted share units indicates a future equity event for Director Azelby, aligning his compensation with future company performance.

Industry Context

This is a routine insider transaction for a director receiving equity compensation, common practice in publicly traded companies across various industries to incentivize long-term commitment and performance.

Comparison to Industry Standards

• The grant of restricted share units (RSUs) at a $0 price is a standard form of equity compensation for directors in many U.S. public companies, similar to practices at peers like McKesson Corporation (MCK) or AmerisourceBergen Corporation (ABC).
• The vesting schedule, tied to a future date or the annual shareholder meeting, is also a common mechanism to ensure director retention and alignment with long-term shareholder interests, consistent with corporate governance best practices.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the long-term performance of the company, potentially fostering decisions that benefit shareholder value.

Next Steps

• The restricted share units are expected to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.

Key Dates

Recommendation

This filing reports a routine equity compensation grant to a director and does not contain information that would fundamentally alter the investment thesis for Cardinal Health. It's a standard practice to align director incentives with shareholder interests, thus supporting a 'hold' recommendation based solely on this specific filing.

Keywords

Cardinal Health, CAH, Robert Azelby, Form 4, Insider Transaction, Restricted Share Units, RSU Grant, Director Compensation, Equity Award